The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

5 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
A novel class of Na+ and Ca2+ channel dual blockers with highly potent anti-ischemic effects.EBI
Institute For Bio-Medical Research
Mechanisms, biology and inhibitors of deubiquitinating enzymes.EBI
Institute For Bio-Medical Research
Small molecule inhibitors of the CCR2b receptor. Part 1: Discovery and optimization of homopiperazine derivatives.EBI
Institute For Bio-Medical Research
Potent inhibitors of acyl-CoA:cholesterol acyltransferase. 2. Structure-activity relationships of novel N-(2,2-dimethyl-2,3-dihydrobenzofuran-7-yl)amides.EBI
Institute For Bio-Medical Research
Novel caffeic acid derivatives: extremely potent inhibitors of 12-lipoxygenase.EBI
Institute For Bio-Medical Research